4.5 Article

Growth signalobody selects functional intrabodies in the mammalian cytoplasm

Journal

BIOTECHNOLOGY JOURNAL
Volume 11, Issue 4, Pages 565-573

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.201500364

Keywords

Growth signalobody; Intrabody; Library selection; Mammalian cell; Receptor tyrosine kinase

Funding

  1. JSPS KAKENHI [15H04190]
  2. Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry
  3. Grants-in-Aid for Scientific Research [16K14486, 15H04190, 25450439] Funding Source: KAKEN

Ask authors/readers for more resources

A versatile strategy to inhibit protein functions in the cytoplasmic environment is eagerly anticipated for drug discovery. In this study, we demonstrate a novel system to directly select functional intrabodies from a library in the mammalian cytoplasm. In this system, a target homo-oligomeric antigen is expressed together with a single-chain Fv (scFv) library that is linked to the cytoplasmic domain of a receptor tyrosine kinase (RTK) in the cytoplasm of murine interleukin-3 (IL-3)-dependent cells. As the tyrosine kinase is activated by dimerization, only scFv-RTK clones that can bind to the target antigen would be oligomerized and transduce a growth signal under the IL-3-deprived condition, which leads to selection of functional intrabodies. To demonstrate this system, we used rabies virus phosphoprotein (RV-P) that forms dimers in the cytoplasm as a target antigen. As a result, functional intrabodies were selected using our system from a naive scFv library as well as from a pre-selected anti-RV-P library generated by phage display. This system may be applied for screening intrabodies that can prevent progression of various severe diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available